Spanish Red Biotech Pipeline

MSD

MK6482

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: MK-6482 Monotherapy in Participants With Advanced Pheochromocytoma/Paraganglioma (PPGL) and Pancreatic Neuroendocrine Tumor (pNET)
Phase: 2Phase II in Spain, 1Phase I